文献速递肿瘤 PET/CT甲状腺核医学

68Ga-FAPI PET/CT评估肝硬化患者肝结节

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient.
PubMed 文献 · Clin Nucl Med · 2020-01-01

该病例提示68Ga-FAPI PET/CT可能有助于肝硬化患者中良性结节与肝细胞癌的鉴别。

要点

  • 肝硬化患者肝实质68Ga-FAPI摄取增高,结节无病理性摄取。
  • 结节因活性低于周围肝实质而清晰显示,提示良性。
  • 组织病理学证实良性结节,提示68Ga-FAPI PET/CT可能有助于鉴别。

核心结论

  • 该病例提示68Ga-FAPI PET/CT可能有助于肝硬化患者中良性结节与肝细胞癌的鉴别。

主要发现

  • 肝硬化患者肝实质68Ga-FAPI摄取增高,但结节无病理性68Ga-FAPI摄取。
  • 结节因活性低于周围肝实质而清晰显示,68Ga-FAPI PET/CT特征提示良性结节。
  • 组织病理学检查 later 证实为良性结节。

关键数值与推荐

  • 结节无病理性68Ga-FAPI摄取且活性低于周围肝实质,该特征提示良性结节并获组织病理学证实。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ga-FAPI PET/CT was performed in a 56-year-old cirrhotic patient with multiple liver nodules, which were suspected of hepatocellular carcinoma by contrast-enhanced magnetic resonance but were not visualized by F-FDG PET/CT. Increased Ga-FAPI liver uptake was observed in this cirrhotic patient. However, the nodules had no pathological Ga-FAPI uptake and were clearly visualized due to the low activity compared with surrounding liver parenchyma. The Ga-FAPI PET/CT features, suggestive of benign nodules, have been later confirmed by histopathological examination. This case suggested that Ga-FAPI PET/CT may be useful in the differentiation between benign nodules and hepatocellular carcinoma in the patient with liver cirrhosis.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhao L, Gu J, Fu K, et al. 68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient. Clin Nucl Med. 2020. PMID: 32332301. doi:10.1097/RLU.0000000000003015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。